Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cellsMolecular Cancer Therapeutics, 2007
- Overexpression of the NOTCH1 Intracellular Domain Inhibits Cell Proliferation and Alters the Neuroendocrine Phenotype of Medullary Thyroid Cancer CellsJournal of Biological Chemistry, 2006
- Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002Surgery, 2006
- Carcinoid TumorsSurgical Oncology Clinics of North America, 2006
- ZM336372, A Raf-1 Activator, Inhibits Growth of Pheochromocytoma CellsJournal of Surgical Research, 2006
- The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?Anti-Cancer Drugs, 2006
- Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cellsSurgery, 2005
- Medullary Thyroid Cancer: The Functions of raf-1 and Human Achaete-scute Homologue-1Thyroid®, 2005
- ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cellsMolecular Cancer Therapeutics, 2005
- The role of human achaete-scute homolog-1 in medullary thyroid cancer cellsSurgery, 2003